anthranilamide has been researched along with rivaroxaban in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, X; Huang, C; Meng, F; Wang, W; Xu, W; Xu, Y; Yuan, J; Zhang, S | 1 |
| Chen, L; Huang, C; Li, Y; Meng, F; Wang, W; Xu, W; Yuan, J; Zhang, S | 1 |
2 other study(ies) available for anthranilamide and rivaroxaban
| Article | Year |
|---|---|
Novel Anthranilamide-Based FXa Inhibitors: Drug Design, Synthesis and Biological Evaluation.
Topics: Anticoagulants; Blood Coagulation; Crystallography, X-Ray; Drug Design; Factor Xa; Factor Xa Inhibitors; Humans; Models, Molecular; Molecular Docking Simulation; ortho-Aminobenzoates; Rivaroxaban; Structure-Activity Relationship; Thrombin; Thrombosis | 2016 |
Synthesis and evaluation of anthranilamide-based derivatives as FXa inhibitors.
Topics: Adult; Anticoagulants; Blood Coagulation; Computational Biology; Factor Xa; Factor Xa Inhibitors; Humans; Male; Models, Molecular; Molecular Targeted Therapy; ortho-Aminobenzoates; Plasma; Rivaroxaban; Thrombin; Thrombosis | 2017 |